High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

PHASE2RecruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions
Metastatic Prostate Cancer
Interventions
DRUG

High dose testosterone

High dose testosterone is administered subcutaneously once monthly until progression or toxicity

Trial Locations (17)

27705

RECRUITING

Durham VA Medical Center, Durham, NC, Durham

28144

RECRUITING

Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC, Salisbury

30033

RECRUITING

Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur

32608

RECRUITING

North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville

32803

RECRUITING

Orlando VA Medical Center, Orlando, FL, Orlando

63106

RECRUITING

St. Louis VA Medical Center John Cochran Division, St. Louis, MO, St Louis

64128

RECRUITING

Kansas City VA Medical Center, Kansas City, MO, Kansas City

77030

NOT_YET_RECRUITING

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

80045

RECRUITING

Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora

97239

RECRUITING

VA Portland Health Care System, Portland, OR, Portland

06516-2770

RECRUITING

VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven

40206-1433

RECRUITING

Robley Rex VA Medical Center, Louisville, KY, Louisville

29401-5799

RECRUITING

Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston

38104-2127

RECRUITING

Memphis VA Medical Center, Memphis, TN, Memphis

37212-2637

RECRUITING

Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville

98108-1532

RECRUITING

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

53705-2254

RECRUITING

William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison

All Listed Sponsors
lead

VA Office of Research and Development

FED